Literature DB >> 24387148

Time to adequate oxygenation following ventilation using the Enk oxygen flow modulator versus a jet ventilator via needle cricothyrotomy in rabbits.

Carrie F P Wong1, Vivian M Yuen, Gordon T C Wong, Jensen To, Michael G Irwin.   

Abstract

INTRODUCTION: Limited information is available on the management of the 'cannot intubate, cannot ventilate' (CICV) situation in infants. We compared the time to achieve adequate oxygenation following rescue ventilation using the Enk oxygen flow modulator (OFM) with a jet ventilator in a simulated CICV situation using the rabbit as an infant respiratory model.
METHODS: Following institutional ethics committee approval, needle cricothyrotomy was performed under direct vision in nine anesthetized rabbits following surgical exposure of the larynx. After ensuring adequate level of anesthesia and analgesia, and confirming proper positioning of the 18G cannula, apnea was induced by the administration of myorelaxant and the SpO2 was allowed to drop to 75% before initiating rescue ventilation via either the OFM or jet ventilator.
RESULTS: Five rabbits were ventilated with the OFM and four with the jet ventilator. Ventilation was maintained with either device for 15 min. All rabbits were successfully rescued using either device. There was no statistical difference in the time required for SpO2 to return to 80%, 85%, 90%, and 95%.
CONCLUSIONS: Both devices facilitated successful rescue ventilation through a needle cricothyrotomy.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  animal model; children; difficult airway; infant

Mesh:

Substances:

Year:  2013        PMID: 24387148     DOI: 10.1111/pan.12289

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  1 in total

1.  Need to consider human factors when determining first-line technique for emergency front-of-neck access.

Authors:  A Timmermann; N Chrimes; C A Hagberg
Journal:  Br J Anaesth       Date:  2016-05-20       Impact factor: 9.166

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.